James Zou, PhD, Stanford University, Stanford, CA, discusses the applications of artificial intelligence (AI) in oncology, including in precision medicines, as well as for early diagnosis with both imaging and molecular data. This interview took place at the American Society for Radiation Oncology (ASTRO) 2022 Congress in San Antonio, Tx.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.